E-LIB Suche - Ergebnisse für: Allan Musinguzi (9235371)

1

Raw deidentified data used to conduct this analysis:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/dataset/Raw_deidentified_data_used_to_conduct_this_analysis_/17226415. , 2021

Link: https://doi.org/10.1371/..

2

Additional file 1 of Acceptance and completion of rifapenti..:

Fred C. Semitala (9235401) ; Allan Musinguzi (9235371) ; Jackie Ssemata (11057059)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Acceptance_and_completion_of_rifapentine-based_TB_preventive_therapy_3HP_among_people_living_with_HIV_PLHIV_in_Kampala_Uganda_patient_and_health_worker_perspectives/14889775. , 2021

Link: https://doi.org/10.6084/..

3

CONSORT flow diagram:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/figure/CONSORT_flow_diagram_/17226448. , 2021

Link: https://doi.org/10.1371/..

4

StaRI: The StaRI checklist for completion:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/StaRI_The_StaRI_checklist_for_completion_/17226409. , 2021

Link: https://doi.org/10.1371/..

5

Options for delivering isoniazid–rifapentine (3HP) for TB p..:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/Options_for_delivering_isoniazid_rifapentine_3HP_for_TB_prevention_3HP_options_implementation_trial_/17226427. , 2021

Link: https://doi.org/10.1371/..

6

Side effects and symptom-based TB screening checklist:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/Side_effects_and_symptom-based_TB_screening_checklist_/17226436. , 2021

Link: https://doi.org/10.1371/..

7

Serious AEs summary:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/Serious_AEs_summary_/17226442. , 2021

Link: https://doi.org/10.1371/..

8

Baseline demographic and clinical characteristics:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/dataset/Baseline_demographic_and_clinical_characteristics_/17226466. , 2021

Link: https://doi.org/10.1371/..

9

CONSORT 2010 checklist of information to include when repor..:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_of_information_to_include_when_reporting_a_randomized_trial_/17226403. , 2021

Link: https://doi.org/10.1371/..

10

3HP acceptance and completion, by subgroup:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/figure/3HP_acceptance_and_completion_by_subgroup_/17226457. , 2021

Link: https://doi.org/10.1371/..

11

3HP Options Trial: Interim analysis statistical analysis pl..:

Fred C. Semitala (4386067) ; Jillian L. Kadota (9235368) ; Allan Musinguzi (9235371)...
https://figshare.com/articles/journal_contribution/3HP_Options_Trial_Interim_analysis_statistical_analysis_plan_/17226421. , 2021

Link: https://doi.org/10.1371/..